Skip to main content
. Author manuscript; available in PMC: 2022 Sep 22.
Published in final edited form as: Cell Rep. 2022 Aug 2;40(5):111156. doi: 10.1016/j.celrep.2022.111156

Figure 1. iNKT cell development is severely impaired in T-Mettl14−/− mice.

Figure 1.

(A) m6A level in total mRNA of CD4+, CD8+ T cells, and iNKT cells (naive and activated) (n = 5–6).

(B) Immunoblot of METTL14 and METTL3 in total thymocytes and TCRβ+ splenocytes in WT and T-Mettl14−/− mice. Data representative of three independent experiments.

(C) Representative staining of lymphocytes in indicated organs from WT and T-Mettl14−/− mice with CD1d/PBS57 tetramer or unloaded CD1d tetramer.

(D and E) Summary of frequencies and cell numbers of iNKT cells in the indicated organs from WT and T-Mettl14−/− mice (n = 5–8). SEM is shown. *p < 0.05, **p < 0.01, ***p < 0.001.